These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 7765570)
1. Atherosclerosis patents: clues to the next drug generation. Suckling KE Biotechnology (N Y); 1994 Dec; 12(13):1379-80. PubMed ID: 7765570 [No Abstract] [Full Text] [Related]
2. The pricing of statins and implications for Pharmaceutical Benefits Scheme expenditure. Clarke PM Med J Aust; 2013 Mar; 198(5):260. PubMed ID: 23496399 [No Abstract] [Full Text] [Related]
3. Expiry of patent protection on statins: effects on pharmaceutical expenditure in Australia. Simoens SR Med J Aust; 2011 Jan; 194(1):52-3; author reply 53-4. PubMed ID: 21449876 [No Abstract] [Full Text] [Related]
4. Statin utilisation--recognising the role of the invisible hand. Minhas R Int J Clin Pract; 2007 Jan; 61(1):3-6. PubMed ID: 17229171 [No Abstract] [Full Text] [Related]
5. Emerging strategies for the treatment of atherosclerosis as seen from the patent literature. Suckling KE Biochem Soc Trans; 1993 Aug; 21 ( Pt 3)(3):660-2. PubMed ID: 8224485 [No Abstract] [Full Text] [Related]
6. Generic atorvastatin and health care costs. Kennally WC N Engl J Med; 2012 Apr; 366(15):1451; author reply 1451. PubMed ID: 22494136 [No Abstract] [Full Text] [Related]
7. Surviving the blockbuster syndrome. Service RF Science; 2004 Mar; 303(5665):1796-9. PubMed ID: 15031490 [No Abstract] [Full Text] [Related]
8. Encouraging generic use can yield significant savings. Zimmerman C Find Brief; 2012 Nov; 15(8):1-3. PubMed ID: 23213854 [TBL] [Abstract][Full Text] [Related]
9. Getting better value from the NHS drug budget. Moon JC; Flett AS; Godman BB; Grosso AM; Wierzbicki AS BMJ; 2010 Dec; 341():c6449. PubMed ID: 21169320 [No Abstract] [Full Text] [Related]
10. Selling Patents to Indian Tribes to Delay the Market Entry of Generic Drugs. Ablavsky G; Larrimore Ouellette L JAMA Intern Med; 2018 Feb; 178(2):179-180. PubMed ID: 29297039 [No Abstract] [Full Text] [Related]
11. Drug use review matters. Mueting M Nebr Nurse; 2007; 40(3):28. PubMed ID: 17915614 [No Abstract] [Full Text] [Related]
15. How to lose a billion pounds. Moon JC; Bogle RG Int J Clin Pract; 2007 Jan; 61(1):2-3. PubMed ID: 17229170 [No Abstract] [Full Text] [Related]
16. [Why patent-protected drugs' cost efficiency should be compared with generic preparations]. Berggren F; Lundin D; Ramsberg J Lakartidningen; 2006 Jan 25-31; 103(4):223-4. PubMed ID: 16491555 [No Abstract] [Full Text] [Related]
17. Long way down--pharmaceutical companies fear falling off 'patent cliff'. Sklan A Pharm Pat Anal; 2012 Jul; 1(3):240. PubMed ID: 24386667 [No Abstract] [Full Text] [Related]
18. Are we living in the end of the blockbuster drug era? Debnath B; Al-Mawsawi LQ; Neamati N Drug News Perspect; 2010 Dec; 23(10):670-84. PubMed ID: 21180653 [TBL] [Abstract][Full Text] [Related]